About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multiple Dose Japanese Bridging Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01057030

Multiple Dose Japanese Bridging Study

The purpose of this study is to assess the safety and tolerability of multiple oral daily doses of BMS-708163 in healthy young male subjects

Lead sponsor: Bristol-Myers Squibb•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Age

20 - 45 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy Japanese and non-Japanese subjects
•Japanese subjects must be first generation Japanese and must demonstrate both maternal and paternal Japanese ancestry
•Non-Japanese subjects must not be of Japanese or Asian descent, ie, neither parent nor grandparent was born in Japan or in any Asian country
•BMI of 19 to 25 kg/m², for Japanese and non-Japanese subjects
•Men ages 20 to 45 years

Exclusion Criteria

•Serum creatinine values above the normal range
•Urine protein or blood levels above the normal range
•Liver function tests above the normal range
•TSH, free T3, or free T4 outside the normal range
•Amylase or lipase levels above the normal range
•Positive Fecal Immunochemical Test (FIT™)

Related studies

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NCT07545473 · Dementia, Neurodegenerative Diseases, and more

RECRUITINGPhase 3

Effect of CAFfeine on Cognition in Alzheimer's Disease

NCT04570085 · Alzheimer Disease

Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases

NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease

Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG

NCT06501495 · Aging, Alzheimer Disease

Tele-Savvy for Latino Caregivers

NCT07290387 · Alzheimer Disease, Dementia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 25, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment22

Start dateMar 2010

Last updatedJan 25, 2011

Condition

Alzheimer Disease

Locations shown

California Clinical Trials Medical Group

Glendale, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 25, 2011Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions